SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-073632
Filing Date
2024-06-14
Accepted
2024-06-14 16:05:22
Documents
11
Period of Report
2024-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K nuvl-20240612.htm   iXBRL 8-K 64977
  Complete submission text file 0000950170-24-073632.txt   188909

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nuvl-20240612.xsd EX-101.SCH 32103
14 EXTRACTED XBRL INSTANCE DOCUMENT nuvl-20240612_htm.xml XML 4703
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 241044694
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)